Ryan Bash

728 citations

25 papers · 517 · h-index 13

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
Cancer Research
- MicroRNA in disease regulation

Papers in

Genetics 17
- Glioma Diagnosis and Treatment 17
Molecular Biology 10

Co-authors: C. Ryan Miller (21 shared papers)David Irvin (5 shared papers)Ralf S. Schmid (7 shared papers)Robert S. McNeill (7 shared papers)Juli R. Bagó (2 shared papers)Shawn Hingtgen (2 shared papers)William C. Zamboni (4 shared papers)Allison N. Schorzman (3 shared papers)
Journals: Neuro-Oncology (9 papers)Cancer Research (6 papers)PLoS ONE (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Plant-Microbe Interactions (1 paper)
Partner nations: United States Italy Ireland

In The Last Decade

Ryan Bash

22 papers receiving 511 citations

Peers

Countries citing papers authored by Ryan Bash

Since Specialization

Citations

This map shows the geographic impact of Ryan Bash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Bash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Bash more than expected).

Fields of papers citing papers by Ryan Bash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Bash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Bash. The network helps show where Ryan Bash may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan Bash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan Bash Line = papers co-authored together Ryan Bash links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model Neuro-Oncology ·Onyinyechukwu Okolie, Juli R. Bagó, Ralf S. Schmid, David Irvin, Ryan Bash, C. Ryan Miller, Shawn Hingtgen	2016	97
2	Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer PLoS ONE ·Carey K. Anders, Bárbara Adamo, Olga Karginova, Allison M. Deal, Sumit Rawal, David B. Darr, Allison N. Schorzman, Charlene Santos, Ryan Bash, Tal Kafri, Lisa A. Carey, C. Ryan Miller, Charles M. Perou, Norman E. Sharpless, William C. Zamboni	2013	74
3	MerTK as a therapeutic target in glioblastoma Neuro-Oncology ·Jing Wu, Lauren N. Frady, Ryan Bash, Stephanie M. Cohen, Allison N. Schorzman, Yu-Ting Su, David Irvin, William C. Zamboni, Xiaodong Wang, Stephen V. Frye, Matthew G. Ewend, Erik P. Sulman, Mark R. Gilbert, H. Shelton Earp, C. Ryan Miller	2017	66
4	Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Olga Karginova, Marni B. Siegel, Amanda E.D. Van Swearingen, Allison M. Deal, Bárbara Adamo, Maria J. Sambade, Soha Bazyar, Nana Nikolaishvili‐Feinberg, Ryan Bash, Sara O’Neal, Katie Sandison, Joel S. Parker, Charlene Santos, David B. Darr, William C. Zamboni, Yueh Z. Lee, C. Ryan Miller, Carey K. Anders	2015	53
5	Evolutionary etiology of high-grade astrocytomas Proceedings of the National Academy of Sciences ·Yurong Song, Qian Zhang, Burak Kutlu, Simone Difilippantonio, Ryan Bash, Debra J. Gilbert, Chaoying Yin, T. Norene O’Sullivan, Chunyu Yang, С. В. Козлов, Elizabeth Bullitt, Ken D. McCarthy, Tal Kafri, David N. Louis, C. Ryan Miller, Leroy Hood, Terry Van Dyke	2013	35
6	Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer Neuro-Oncology ·Amanda E.D. Van Swearingen, Maria J. Sambade, Marni B. Siegel, Shivani Sud, Robert S. McNeill, Samantha M. Bevill, Xin Chen, Ryan Bash, Louisa A. Mounsey, Brian T. Golitz, Charlene Santos, Allison M. Deal, Joel S. Parker, Naim U. Rashid, C. Ryan Miller, Gary L. Johnson, Carey K. Anders	2017	32
7	Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models Brain Pathology ·David Irvin, Robert S. McNeill, Ryan Bash, C. Ryan Miller	2016	32
8	Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide Neuro-Oncology ·Ralf S. Schmid, Jeremy M. Simon, Mark Vitucci, Robert S. McNeill, Ryan Bash, Andrea M. Werneke, Lauren Huey, Kristen White, Matthew G. Ewend, Jing Wu, C. Ryan Miller	2016	24
9	MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment Neuro-Oncology Advances ·Yuting Su, Madison Butler, Meili Zhang, Wei Zhang, Hua Song, Lee Hwang, Andy D. Tran, Ryan Bash, Allison N. Schorzman, Ying Pang, Guangyang Yu, William C. Zamboni, Xiaodong Wang, Stephen V. Frye, Christopher R. Miller, Dragan Maric, Masaki Terabe, Mark R. Gilbert, H. Shelton Earp, Jing Wu	2020	24
10	Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma Neuro-Oncology ·Mark Vitucci, David Irvin, Robert S. McNeill, Ralf S. Schmid, Jeremy M. Simon, Harshil Dhruv, Marni B. Siegel, Andrea M. Werneke, Ryan Bash, Seungchan Kim, Michael E. Berens, C. Ryan Miller	2017	15
11	PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition PLoS ONE ·Robert S. McNeill, Emily E. Stroobant, Erin Smithberger, Demitra A. Canoutas, Madison Butler, Abigail Shelton, Shrey Patel, Juanita C. Limas, Kasey Skinner, Ryan Bash, Ralf S. Schmid, C. Ryan Miller	2018	15
12	Attachment to Roots and Virulence of a chvB Mutant of Agrobacterium tumefaciens Are Temperature Sensitive Molecular Plant-Microbe Interactions ·Ryan Bash, Ann G. Matthysse	2002	14
13	An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases JCI Insight ·Christian T. Stackhouse, Joshua C. Anderson, Zongliang Yue, Thanh Nguyen, Nicholas Eustace, Catherine P. Langford, Jelai Wang, James Rowland, Chuan Xing, Fady M. Mikhail, Xiangqin Cui, Hasan Alrefai, Ryan Bash, Kevin J. Lee, Eddy S. Yang, Anita B. Hjelmeland, C. Ryan Miller, Jake Y. Chen, G. Yancey Gillespie, Christopher D. Willey	2022	12
14	Modeling Astrocytoma Pathogenesis <em>In Vitro</em> and <em>In Vivo</em> Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice Journal of Visualized Experiments ·Robert S. McNeill, Ralf S. Schmid, Ryan Bash, Mark Vitucci, Kristen White, Andrea M. Werneke, Brian H. Constance, Byron Huff, C. Ryan Miller	2014	8
15	Deciphering Cancer Complexities in Genetically Engineered Mice Cold Spring Harbor Symposia on Quantitative Biology ·Karl Simin, Reginald Hill, Ying Song, Qisheng Zhang, Ryan Bash, Robert D. Cardiff, Cheng Yin, Andrew Xiao, Katharine McCarthy, T. Van Dyke	2005	8
16	DRES-13. DUAL KINASE INHIBITION TO COMBAT EGFR-INHIBITOR RESISTANCE IN GLIOBLASTOMA Neuro-Oncology ·Erin Smithberger, Abigail Shelton, Madison Butler, Álex Flores, Ryan Bash, Steven P. Angus, Michael P. East, Noah Sciaky, Harshil Dhruv, Gary L. Johnson, Michael E. Berens, Frank B. Furnari, C. Ryan Miller	2019	2
17	Abstract 3302: Roles of cortical and subventricular GFAP+ astrocytes in initiation of astrocytomas Cancer Research ·Ralf S. Schmid, Ryan Bash, Andrea M. Werneke, C. Ryan Miller	2012	1
18	Abstract 1125: Elucidating the transcriptomic response to EGFR-targeted therapy in EGFR-driven glioblastoma Cancer Research ·Benjamin Lin, Julia Ziebro, Kasey Skinner, Abigail Shelton, Erin Smithberger, Ryan Bash, Frank B. Furnari, C. Ryan Miller	2022	1
19	CSIG-10. GENOTYPE – KINOME GUIDED DEVELOPMENT OF PRECISION EGFR-TARGETED THERAPEUTICS FOR GLIOBLASTOMA Neuro-Oncology ·Erin Smithberger, Abigail Shelton, Madison Butler, Allie Stamper, Ryan Bash, Steven P. Angus, Michael P. East, Gary L. Johnson, Michael E. Berens, Frank B. Furnari, C. Ryan Miller	2020	1
20	P4-17-04: Pharmacokinetic Disposition of PEGylated Liposomal Doxorubicin Compared with Non-Liposomal Doxorubicin in an Intracranial Breast Cancer Murine Model. Cancer Research ·CK Anders, Bárbara Adamo, MD Walsh, Olga Karginova, DB Darr, AM Deal, Santos Cm, Ryan Bash, SK Hanna, LA Carey, C. E. Miller, Norman E. Sharpless, W. Zamboni	2011	1

About Ryan Bash

Ryan Bash is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 25 papers that have together received 517 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (6 papers), Cancer Genomics and Diagnostics (4 papers), MicroRNA in disease regulation (3 papers), Nanoplatforms for cancer theranostics (3 papers), Lung Cancer Research Studies (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Genetics (183 citations), Cancer Research (120 citations), Developmental Neuroscience (30 citations), Immunology (129 citations) and Neurology (43 citations). Ryan Bash has collaborated with scholars based in United States, Italy and Ireland. Frequent co-authors include C. Ryan Miller, David Irvin, Ralf S. Schmid, Robert S. McNeill, Juli R. Bagó, Shawn Hingtgen, William C. Zamboni, Allison N. Schorzman, Charlene Santos and Allison M. Deal. Their work appears in journals such as Neuro-Oncology, Cancer Research, PLoS ONE, Molecular Cancer Therapeutics and Molecular Plant-Microbe Interactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ryan Bash

Impact in

Papers in i

In The Last Decade

Ryan Bash

Peers

Countries citing papers authored by Ryan Bash

Fields of papers citing papers by Ryan Bash

All Works

About Ryan Bash

Explore authors with similar magnitude of impact

Papers in